Spots Global Cancer Trial Database for pancreatic ductal adenocarcinoma (pda)
Every month we try and update this database with for pancreatic ductal adenocarcinoma (pda) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma | NCT02715804 | Pancreatic Duct... | Biological: PEG... Placebo nab-Paclitaxel Gemcitabine | 18 Years - | Halozyme Therapeutics | |
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma | NCT02715804 | Pancreatic Duct... | Biological: PEG... Placebo nab-Paclitaxel Gemcitabine | 18 Years - | Halozyme Therapeutics | |
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma | NCT02715804 | Pancreatic Duct... | Biological: PEG... Placebo nab-Paclitaxel Gemcitabine | 18 Years - | Halozyme Therapeutics | |
RNA Precision Oncology in Advanced Pancreatic Cancer | NCT04476537 | Pancreatic Canc... | OncoTreat | 18 Years - | Columbia University |